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Mad proteins are transcriptional repressors that
antagonize transcriptional activation and
transformation by Myc oncoprotein; recent findings
suggest that they repress transcription by recruiting
histone deacetylases to target sites on DNA.
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The rate of transcription of an individual gene is con-
trolled by both positively acting and negatively acting
(repressing) protein factors, which interact with regulatory
sequences in the promoter or enhancer region of that
gene. The precise mechanisms by which transcription
factors exert either stimulating or repressing effects are
still unclear and a focus of intense research. Results
reported in a flurry of recent papers [1–7] have provided
new insights into the mechanism of transcriptional repres-
sion; the new findings suggest that at least some repres-
sors of transcription act by modifying the structure of the
chromatin into which the gene is packed. More specifi-
cally, the idea is that repression involves the recruitment
to a gene’s promoter of histone deacetylases, enzymes that
remove acetyl groups from specific lysines in the tails of
histone H3 and H4. Repression is thus suggested to result
from changes in the degree and stability of nucleosomal
packaging.
One of the proteins for which this mechanism is sug-
gested is mammalian Mad-1. Mad-1 is one of a group of
five closely related proteins — Mad-1, Mad-2 (Mxi-1),
Mad-3, Mad-4 and Mnt (Rox) — that all have
helix–loop–helix/leucine zipper domains and that bind to
DNA and repress transcription as obligate heterodimers
with a common partner protein known as Max. Max was
discovered, however, not as a partner of Mad proteins,
but by virtue of its ability to form heterodimers with Myc
proteins; Max binds in a mutually exclusive manner to
either Myc or Mad. Myc–Max complexes, in contrast to
Mad–Max complexes, are activators of transcription;
complex formation with Max is required for Myc to acti-
vate gene expression and transform cells. Mad proteins
thus antagonize the transforming and mitogenic func-
tions of Myc proteins by competing for binding to Max
and to DNA. Together, the three groups of proteins form
a small, evolutionarily conserved network that acts as a
central regulator of proliferation and apoptosis in mam-
malian cells (for review, see [8]).
For Mad proteins to repress transcription, two of their
domains are of critical importance. One is the basic
region/helix–loop–helix/leucine zipper domain required
for both DNA binding and dimerization with Max. The
second is a short, amino-terminal amphipathic helix: dele-
tions or point mutations in this helix do not abolish DNA
binding, but they do impair the ability of a Mad protein to
repress transcription or suppress Myc-dependent transfor-
mation [9,10]. Two mouse proteins that interact with Mad
via this repression domain have been identified using the
yeast two-hybrid cloning method; these are called mSin3A
and mSin3B on account of their sequence similarity to the
budding yeast Sin3 protein [9,10]. Formation of a ternary
Max–Mad–mSin3 complex can be demonstrated in vitro
and in vivo, and mutations of Mad that disrupt complex
formation with Sin3 lead to a loss of transcriptional repres-
sion. Strikingly, the Mad repression domain functions in
yeast when tethered to a heterologous DNA-binding
domain, and this repression is dependent on the presence
of a wild-type SIN3 allele [11]. Taken together, these
results show that Mad represses transcription via recruit-
ment of mSin3. 
The yeast SIN3 gene was first identified by a mutation
that allows expression of the HO gene in the absence of its
transcriptional activator, Swi5p [12,13]. HO encodes an
endonuclease required for the recombination at the MAT
locus that causes mating-type switching. HO expression is
restricted to the mother cells in a haploid lineage, but sin3
mutations derepress the HO gene in daughter cells, sug-
gesting that the Sin3 protein is a negative regulator of HO
transcription. However, sin3 mutations are not specific for
HO gene expression — for example, they also allow
expression of the meiotic genes, such as IME2, in the
absence of their cognate activator and of starvation, the
natural inducer of their expression [14]. Thus, Sin3 acts as
a more general, but by no means universal, negative regu-
lator of transcription. Studies in yeast have also estab-
lished that SIN3 acts as part of a small genetic pathway; it
is, for example, epistatic to an unrelated gene, RPD3,
mutations of which have a very similar phenotype to sin3
mutations [14,15]. The sequence of Sin3 revealed four
paired amphipathic helix motifs, reminiscent of the
helix–loop–helix domain, strongly suggesting that Sin3
acts at least in part by making multiple protein–protein
interactions [16]. 
As the next piece of the puzzle, two independent lines of
research identified Rpd3 and a related mammalian protein
as components of histone deacetylase complexes. In yeast,
two distinct deacetylase complexes were identified, one of
which, termed HDA, was purified, micro-sequenced and
cloned. HDA turned out to contain a protein, Hda-1, that
is closely related to Rpd3. Subsequently, Rpd3 itself was
found to be a component of the second deacetylase
complex, HDB [17]. In mammalian cells, purification of
proteins that bind to trapoxin, a highly selective inhibitor
of histone deacetylases, led to the identification of two pro-
teins: Hdac1, related to Rpd3, and RbAP48, previously
identified as a protein that interacts with the retinoblas-
toma protein (which can also repress cellular transcription)
[18]. A mammalian homologue of Rpd3, termed Hdac2,
was identified in a two-hybrid screen using YY-1, a tran-
scriptional repressor as bait [19]. These  findings suggested
a model in which Mad proteins recruit Sin3 and thereby
activate a pathway leading to histone deacetylation at
Mad–Max binding sites. This prediction has now received
firm support by the recent papers [1–7], which further
show that deacetylases are directly recruited by Sin3 to
form a high molecular weight protein complex (Figure 1).
While the individual papers provide a wealth of detailed
information, they share a set of common conclusions.
The first is that immunoprecipitations with antibodies
against mSin3 specifically co-immunoprecipitate both
mammalian histone deacetylase proteins, Hdac1 and
Hdac2, demonstrating that they are components of a
common protein complex. This complex has histone
deacetylase activity in vitro. Within Sin3, a specific
domain has been identified that is required and sufficient
for recruiting Hdac proteins. When tethered to a heterolo-
gous DNA-binding domain, this domain is sufficient to
mediate repression of basal transcription, suggesting that
Sin3 represses via recruitment of histone deacetylases.
Further, Mad, Sin3 and Hdac2 can be shown to form a
ternary complex that has histone deacetylase activity.
Together, the data strongly suggest that Mad can recruit,
via its interaction with mSin3, histone deacetylase activity
to its target sites on DNA.
A twist in the story is introduced by the papers of Heinzel
et al. [7] and Alland et al. [2]. In both, mSin3 is found to
interact, not only with mRpd3, but also with N-CoR, a
protein that was previously shown to mediate the repres-
sive effects of non-liganded thyroid hormone receptor.
Repression by Mad requires the function of all three pro-
teins, mSin3, Rpd3 and N-CoR, as antibodies against each
one impairs the ability of a GAL4–Mad fusion protein to
repress a minimal promoter [7]. The interaction between
Sin3 and N-CoR is direct, as it can be directed both in the
two-hybrid assay and in vitro [2,7]. This is in contrast to
the interactions between either mSin3 or N-CoR and
histone deacetylase, for which no direct interactions could
be demonstrated (although they co-immunoprecipitate in
vivo, as described above). The potential exception to this
is in yeast, where Sin3 and Rpd3 interact in the two-
hybrid assay; however, the presence of endogenous yeast
components in the complex is not excluded by the experi-
ments. The data suggest that additional factors exist that
help to assemble histone deacetylase complexes. Indeed,
immunoprecipitations from metabolically labelled cells
have show that there are additional proteins in these com-
plexes, two of which, SAP18 and SAP30, are identified in
the paper by Zhang et al. [1].
What are the functional implications of these findings?
Both Hassig et al. [4] and Laherty et al. [6] show that
inhibitors of histone deacetylases partly revert repression
by Mad proteins, arguing for a causal role of deacetylation
in transcriptional repression [4,6]. Sommer et al. [3] go one
step further to show that deacetylase inhibitors impair the
ability of Mad to inhibit cell proliferation upon microinjec-
tion in quiescent cells [3]. However, whether histones or
other proteins involved in transcription are the actual
targets for deacetylation is not yet clear. A note of caution
is also warranted, as mutations in yeast deacetylases have
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Figure 1
A model showing how Myc–Max and Mad–Max heterodimers may
regulate gene expression in proliferating and differentiated cells,
respectively. (See text for details.)
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complicated effects on gene expression and indeed lead to
a loss of telomeric silencing [16]. Thus, no simple correla-
tion holds between histone deacetylation and gene
expression, and whether deacetylation of histone is really
the driving force of repression must remain open.
Finally, if Mad proteins recruit histone deacetylases, do
Myc proteins act by recruiting histone acetylases and
opening chromatin? There is no direct evidence to
support this notion. But as Alland et al. [2] point out, the
present papers are not the first to draw a link between the
function of Myc proteins and chromatin structure. Previ-
ously, one of the oncogenes that cooperate with myc in the
genesis of B-cell lymphomas, bmi-1, has been found to
encode a member of the polycomb family of proteins [20].
These chromatin proteins form multi-protein complexes
that are thought to organize large chromatin domains
within chromosomes and act as a molecular ‘memory’
during Drosophila development. If such proteins sense the
presence or absence of histone acetylation, local changes
in acetylation induced by Myc or Mad proteins might
translate into long-lasting and stable changes in gene
expression — such as one might expect to occur during
differentiation — via their effects on the binding of poly-
comb group proteins. Potentially, then, the present papers
provide a glimpse as to how the control of cellular prolifer-
ation by Myc proteins is linked to cellular differentiation.
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